J Cancer
2022; 13(15):3713-3715.
doi:10.7150/jca.80633 This issueCite
Erratum
Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum
Li Yuan1*, Kai Zhang2*, Meng-Meng Zhou3, Harpreet S. Wasan4, Fang-Fang Tao5, Qing-Ying Yan1, Guan Feng1, Yin-Shan Tang6, Min-He Shen2, Sheng-Lin Ma7, Shan-Ming Ruan2,7 ✉
1. The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, china 2. Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, Zhejiang, China 3. Department of traditional Chinese medicine, The First people's Hospital of Quzhou, 324000, Zhejiang, China 4. Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, W12 0HS, UK 5. Department of Immunology and Microbiology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China 6. Department of Rehabilitation in Traditional Chinese Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China 7. Department of Oncology, The Forth Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, Zhejiang, China *These authors contributed equally to this work.
✉ Corresponding author: Shan-Ming Ruan; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, No. 54, Youdian Road, Shangcheng District, Hangzhou, Zhejiang, China; Zip code: 310006; Email: shanmingruanedu.cn
More
Citation:
Yuan L, Zhang K, Zhou MM, Wasan HS, Tao FF, Yan QY, Feng G, Tang YS, Shen MH, Ma SL, Ruan SM. Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum. J Cancer 2022; 13(15):3713-3715. doi:10.7150/jca.80633. https://www.jcancer.org/v13p3713.htm
Yuan, L., Zhang, K., Zhou, M.M., Wasan, H.S., Tao, F.F., Yan, Q.Y., Feng, G., Tang, Y.S., Shen, M.H., Ma, S.L., Ruan, S.M. (2022). Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum. Journal of Cancer, 13(15), 3713-3715. https://doi.org/10.7150/jca.80633.
ACS
Yuan, L.; Zhang, K.; Zhou, M.M.; Wasan, H.S.; Tao, F.F.; Yan, Q.Y.; Feng, G.; Tang, Y.S.; Shen, M.H.; Ma, S.L.; Ruan, S.M. Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum. J. Cancer 2022, 13 (15), 3713-3715. DOI: 10.7150/jca.80633.
NLM
Yuan L, Zhang K, Zhou MM, Wasan HS, Tao FF, Yan QY, Feng G, Tang YS, Shen MH, Ma SL, Ruan SM. Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum. J Cancer 2022; 13(15):3713-3715. doi:10.7150/jca.80633. https://www.jcancer.org/v13p3713.htm
CSE
Yuan L, Zhang K, Zhou MM, Wasan HS, Tao FF, Yan QY, Feng G, Tang YS, Shen MH, Ma SL, Ruan SM. 2022. Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum. J Cancer. 13(15):3713-3715.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Global reach, higher impact
